Stress kinases in the modulation of metabolism and energy balance

Journal of Molecular Endocrinology

Volumn 55, Issue 2, 2015, Pages R12-R22

  Manieri, Elisa ^a,b   Sabio, Guadalupe ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Adipose tissue; Brain and signal transduction; JNK; Metabolism; Obesity; p38; SAPK; Stress

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ADIPOSE TISSUE; BONE MARROW CELL; CENTRAL NERVOUS SYSTEM; ENERGY BALANCE; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; HUMAN; INSULIN SENSITIVITY; LIPID STORAGE; LIVER; LIVER METABOLISM; METABOLIC STRESS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; ANIMAL; ENZYME ACTIVATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MAP KINASE SIGNALING SYSTEM; MICE; OBESITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84944313564     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0146     Document Type: Review

References (97)

1. Aguirre V, Uchida T, Yenush L, Davis R & White MF 2000 The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). Journal of Biological Chemistry 275 9047–9054. (doi:10.1074/jbc.275.12.9047)
2. Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, McIlrath J, Carr JM, Armit LJ, Clacher C et al. 2005 Generation and characterization of p38b (MAPK11) gene-targeted mice. Molecular and Cellular Biology 25 10454–10464. (doi:10.1128/MCB.25.23.10454-10464.2005)
3. Belgardt BF & Bruning JC 2010 CNS leptin and insulin action in the control of energy homeostasis. Annals of the New York Academy of Sciences 1212 97–113. (doi:10.1111/j.1749-6632.2010.05799.x)
4. Belgardt BF, Mauer J, Wunderlich FT, Ernst MB, Pal M, Spohn G, Bronneke HS, Brodesser S, Hampel B, Schauss AC et al. 2010 Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. PNAS 107 6028–6033. (doi:10.1073/pnas.1001796107)
5. Bertola A, Park O & Gao B 2013 Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology 58 1814–1823. (doi:10.1002/hep.26419)
6. Bogoyevitch MA & Kobe B 2006 Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiology and Molecular Biology Reviews 70 1061–1095. (doi:10.1128/MMBR.00025-06)
7. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, Kyuuma M, Takeshita T, Flavell RA & Davis RJ 2003 Mechanism of p38 MAP kinase activation in vivo. Genes and Development 17 1969–1978. (doi:10.1101/gad.1107303)
8. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D & Kahn CR 2000 Role of brain insulin receptor in control of body weight and reproduction. Science 289 2122–2125. (doi:10.1126/science.289.5487.2122)
9. Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, Denys A, Feldmann M, Brennan FM & Foxwell BM 2004 A novel mechanism for TNFa regulation by p38 MAPK: involvement of NF-kB with implications for therapy in rheumatoid arthritis. Journal of Immunology 173 6928–6937. (doi:10.4049/jimmunol.173.11.6928)
10. Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM & Collins S 2004 p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene. Molecular and Cellular Biology 24 3057–3067. (doi:10.1128/MCB.24.7.3057-3067.2004)
11. Cao W, Collins QF, Becker TC, Robidoux J, Lupo EG Jr, Xiong Y, Daniel KW, Floering L & Collins S 2005 p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. Journal of Biological Chemistry 280 42731–42737. (doi:10.1074/jbc.M506223200)
12. Chang L & Karin M 2001 Mammalian MAP kinase signalling cascades. Nature 410 37–40. (doi:10.1038/35065000)
13. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, Lancaster GI, Southgate RJ, Bruce CR, Duffy SJ et al. 2008 HSP72 protects against obesity-induced insulin resistance. PNAS 105 1739–1744. (doi:10.1073/pnas.0705799105)
14. Contreras C, Gonzalez F, Ferno J, Dieguez C, Rahmouni K, Nogueiras R & Lopez M 2015 The brain and brown fat. Annals of Medicine 47 150–168. (doi:10.3109/07853890.2014.919727)
15. Cuadrado A & Nebreda AR 2010 Mechanisms and functions of p38 MAPK signalling. Biochemical Journal 429 403–417. (doi:10.1042/BJ20100323)
16. Czaja MJ 2010 JNK regulation of hepatic manifestations of the metabolic syndrome. Trends in Endocrinology and Metabolism 21 707–713. (doi:10.1016/j.tem.2010.08.010)
17. Davis RJ 2000 Signal transduction by the JNK group of MAP kinases. Cell 103 239–252. (doi:10.1016/S0092-8674(00)00116-1)
18. Deak M, Clifton AD, Lucocq LM & Alessi DR 1998 Mitogen- and stressactivated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO Journal 17 4426–4441. (doi:10.1093/emboj/17.15.4426)
19. Engelman JA, Lisanti MP & Scherer PE 1998 Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. Journal of Biological Chemistry 273 32111–32120. (doi:10.1074/jbc.273.48.32111)
20. Enslen H, Brancho DM & Davis RJ 2000 Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO Journal 19 1301–1311. (doi:10.1093/emboj/19.6.1301)
21. Ferrante AW Jr 2013 The immune cells in adipose tissue. Diabetes, Obesity & Metabolism 15 (Suppl 3) 34–38. (doi:10.1111/dom.12154)
22. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M & Reitman ML 2000 Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. Journal of Clinical Investigation 105 271–278. (doi:10.1172/JCI7901)
23. Gehart H, Kumpf S, Ittner A & Ricci R 2010 MAPK signalling in cellular metabolism: stress or wellness? EMBO Reports 11 834–840. (doi:10.1038/embor.2010.160)
24. Gonzalez-Teran B, Cortes JR, Manieri E, Matesanz N, Verdugo A, Rodriguez ME, Gonzalez-Rodriguez A, Valverde AM, Martin P, Davis RJ et al. 2013 Eukaryotic elongation factor 2 controls TNFa translation in LPS-induced hepatitis. Journal of Clinical Investigation 123 164–178. (doi:10.1172/JCI65124)
25. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B & Davis RJ 1996 Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO Journal 15 2760–2770.
26. Haefliger JA, Tawadros T, Meylan L, Gurun SL, Roehrich ME, Martin D, Thorens B & Waeber G 2003 The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic b cells. Journal of Cell Science 116 1463–1469. (doi:10.1242/jcs.00356)
27. Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA & Davis RJ 2013 JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339 218–222. (doi:10.1126/science.1227568)
28. Haslam DW & James WP 2005 Obesity. Lancet 366 1197–1209. (doi:10.1016/S0140-6736(05)67483-1)
29. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M & Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420 333–336. (doi:10.1038/nature01137)
30. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444 860–867. (doi:10.1038/nature05485)
31. Hotamisligil GS, Shargill NS & Spiegelman BM 1993 Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259 87–91. (doi:10.1126/science.7678183)
32. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE & Spiegelman BM 1996a Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 1377–1379. (doi:10.1126/science.274.5291.1377)
33. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF & Spiegelman BM 1996b IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNFa- and obesity-induced insulin resistance. Science 271 665–668. (doi:10.1126/science.271.5249.665)
34. Imbernon M, Beiroa D, Vazquez MJ, Morgan DA, Veyrat-Durebex C, Porteiro B, Diaz-Arteaga A, Senra A, Busquets S, Velasquez DA et al. 2013 Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/ JNK1 pathways. Gastroenterology 144 636–649. (doi:10.1053/j.gastro.2012.10.051)
35. Ittner A, Block H, Reichel CA, Varjosalo M, Gehart H, Sumara G, Gstaiger M, Krombach F, Zarbock A & Ricci R 2012 Regulation of PTEN activity by p38d-PKD1 signaling in neutrophils confers inflammatory responses in the lung. Journal of Experimental Medicine 209 2229–2246. (doi:10.1084/jem.20120677)
36. Jaeschke A, Czech MP & Davis RJ 2004 An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes and Development 18 1976–1980. (doi:10.1101/gad.1216504)
37. Jaeschke A, Rincon M, Doran B, Reilly J, Neuberg D, Greiner DL, Shultz LD, Rossini AA, Flavell RA & Davis RJ 2005 Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mousemodel of type I diabetes. PNAS 102 6931–6935. (doi:10.1073/pnas.0502143102)
38. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S & Weir GC 1999 Chronic hyperglycemia triggers loss of pancreatic b cell differentiation in an animal model of diabetes. Journal of Biological Chemistry 274 14112–14121. (doi:10.1074/jbc.274.20.14112)
39. Juge-Aubry CE, Hammar E, Siegrist-Kaiser C, Pernin A, Takeshita A, Chin WW, Burger AG & Meier CA 1999 Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor a by phosphorylation of a ligand-independent trans-activating domain. Journal of Biological Chemistry 274 10505–10510. (doi:10.1074/jbc.274.15.10505)
40. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S & Weir GC 2002 Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. Journal of Biological Chemistry 277 30010–30018. (doi:10.1074/jbc.M202066200)
41. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M & Yamasaki Y 2005 Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic b-cell dysfunction and insulin resistance. International Journal of Biochemistry & Cell Biology 37 1595–1608. (doi:10.1016/j.biocel.2005.04.003)
42. Kang YJ, Chen J, Otsuka M, Mols J, Ren S, Wang Y & Han J 2008 Macrophage deletion of p38a partially impairs lipopolysaccharide induced cellular activation. Journal of Immunology 180 5075–5082. (doi:10.4049/jimmunol.180.7.5075)
43. Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB et al. 2004a Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53 1060–1067. (doi:10.2337/diabetes.53.4.1060)
44. Kim JK, Gimeno RE, Higashimori T, Kim HJ, Choi H, Punreddy S, Mozell RL, Tan G, Stricker-Krongrad A, Hirsch DJ et al. 2004b Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. Journal of Clinical Investigation 113 756–763. (doi:10.1172/JCI200418917)
45. Klover PJ, Zimmers TA, Koniaris LG & Mooney RA 2003 Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52 2784–2789. (doi:10.2337/diabetes.52.11.2784)
46. Knebel A, Morrice N & Cohen P 2001 A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38d. EMBO Journal 20 4360–4369. (doi:10.1093/emboj/20.16.4360)
47. Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD & Leclercq IA 2010 Kupffer cell activation is a causal factor for hepatic insulin resistance. American Journal of Physiology. Gastrointestinal and Liver Physiology 298 G107–G116. (doi:10.1152/ajpgi.00391.2009)
48. Lanuza-Masdeu J, Arevalo MI, Vila C, Barbera A, Gomis R & Caelles C 2013 In vivo JNK activation in pancreatic b-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes 62 2308–2317. (doi:10.2337/db12-1097)
49. Lee J, Sun C, Zhou Y, Lee J, Gokalp D, Herrema H, Park SW, Davis RJ & Ozcan U 2011 p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis. Nature Medicine 17 1251–1260. (doi:10.1038/nm.2449)
50. Lopez M & Tena-Sempere M 2015 Estrogens and the control of energy homeostasis: a brain perspective. Trends in Endocrinology and Metabolism 26 411–421. (doi:10.1016/j.tem.2015.06.003)
51. Mansuy-Aubert V, Zhou QL, Xie X, Gong Z, Huang JY, Khan AR, Aubert G, Candelaria K, Thomas S, Shin DJ et al. 2013 Imbalance between neutrophil elastase and its inhibitor a1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metabolism 17 534–548. (doi:10.1016/j.cmet.2013.03.005)
52. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y & Hori M 2004 Modulation of the JNK pathway in liver affects insulin resistance status. Journal of Biological Chemistry 279 45803–45809. (doi:10.1074/jbc.M406963200)
53. Nathan C 2006 Neutrophils and immunity: challenges and opportunities. Nature Reviews. Immunology 6 173–182. (doi:10.1038/nri1785)
54. Neels JG & Olefsky JM 2006 Inflamed fat: what starts the fire? Journal of Clinical Investigation 116 33–35. (doi:10.1172/JCI27280)
55. Obici S, Feng Z, Karkanias G, Baskin DG & Rossetti L 2002 Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature Neuroscience 5 566–572. (doi:10.1038/nn0602-861)
56. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH & Hotamisligil GS 2004 Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 457–461. (doi:10.1126/science.1103160)
57. Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW & Plevin R 1997 Stress-activated protein kinases: activation, regulation and function. Cellular Signalling 9 403–410. (doi:10.1016/S0898-6568(97)00042-9)
58. Pirianov G, Brywe KG, Mallard C, Edwards AD, Flavell RA, Hagberg H & Mehmet H 2007 Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. Journal of Cerebral Blood Flow and Metabolism 27 1022–1032. (doi:10.1038/sj.jcbfm.9600413)
59. Prada PO, Zecchin HG, Gasparetti AL, Torsoni MA, Ueno M, Hirata AE, Corezola do Amaral ME, Hoer NF, Boschero AC & Saad MJ 2005 Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146 1576–1587. (doi:10.1210/en.2004-0767)
60. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB & Spiegelman BM 2001 Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARg coactivator-1. Molecular Cell 8 971–982. (doi:10.1016/S1097-2765(01)00390-2)
61. Qiao L, MacDougald OA & Shao J 2006 CCAAT/enhancer-binding protein a mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase. Journal of Biological Chemistry 281 24390–24397. (doi:10.1074/jbc.M603038200)
62. Remy G, Risco AM, Inesta-Vaquera FA, Gonzalez-Teran B, Sabio G, Davis RJ & Cuenda A 2010 Differential activation of p38MAPK isoforms by MKK6 and MKK3. Cellular Signalling 22 660–667. (doi:10.1016/j.cellsig.2009.11.020)
63. Risco A, del Fresno C, Mambol A, Alsina-Beauchamp D, MacKenzie KF, Yang HT, Barber DF, Morcelle C, Arthur JS, Ley SC et al. 2012 p38g and p38d kinases regulate the toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation. PNAS 109 11200–11205. (doi:10.1073/pnas.1207290109)
64. Roden M 2004 How free fatty acids inhibit glucose utilization in human skeletal muscle. News in Physiological Sciences 19 92–96.
65. Sabio G & Davis RJ 2010 Jun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends in Biochemical Sciences 35 490–496. (doi:10.1016/j.tibs.2010.04.004)
66. Sabio G & Davis RJ 2014 TNF and MAP kinase signalling pathways. Seminars in Immunology 26 237–245. (doi:10.1016/j.smim.2014.02.009)
67. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK & Davis RJ 2008 A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322 1539–1543. (doi:10.1126/science.1160794)
68. Sabio G, Cavanagh-Kyros J, Ko HJ, Jung DY, Gray S, Jun JY, Barrett T, Mora A, Kim JK & Davis RJ 2009 Prevention of steatosis by hepatic JNK1. Cell Metabolism 10 491–498. (doi:10.1016/j.cmet.2009.09.007)
69. Sabio G, Kennedy NJ, Cavanagh-Kyros J, Jung DY, Ko HJ, Ong H, Barrett T, Kim JK & Davis RJ 2010a Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Molecular and Cellular Biology 30 106–115. (doi:10.1128/MCB.01162-09)
70. Sabio G, Cavanagh-Kyros J, Barrett T, Jung DY, Ko HJ, Ong H, Morel C, Mora A, Reilly J, Kim JK et al. 2010b Role of the hypothalamic–pituitary–thyroid axis in metabolic regulation by JNK1. Genes and Development 24 256–264. (doi:10.1101/gad.1878510)
71. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE & Czaja MJ 2006 JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43 163–172. (doi:10.1002/hep.20999)
72. Shulman GI 2000 Cellular mechanisms of insulin resistance. Journal of Clinical Investigation 106 171–176. (doi:10.1172/JCI10583)
73. Singh R, Wang Y, Xiang Y, Tanaka KE, Gaarde WA & Czaja MJ 2009 Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49 87–96. (doi:10.1002/hep.22578)
74. Solinas G, Naugler W, Galimi F, Lee MS & Karin M 2006 Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. PNAS 103 16454–16459. (doi:10.1073/pnas.0607626103)
75. Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, Grivennikov S, Wynshaw-Boris A, Scadeng M, Olefsky JM et al. 2007 JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metabolism 6 386–397. (doi:10.1016/j.cmet.2007.09.011)
76. Speakman JR 2010 FTO effect on energy demand versus food intake. Nature 464 E1 discussion E2. (doi:10.1038/nature08807)
77. Standen CL, Kennedy NJ, Flavell RA & Davis RJ 2009 Signal transduction cross talk mediated by Jun N-terminal kinase-interacting protein and insulin receptor substrate scaffold protein complexes. Molecular and Cellular Biology 29 4831–4840. (doi:10.1128/MCB.00155-09)
78. Sumara G, Formentini I, Collins S, Sumara I, Windak R, Bodenmiller B, Ramracheya R, Caille D, Jiang H, Platt KA et al. 2009 Regulation of PKD by the MAPK p38d in insulin secretion and glucose homeostasis. Cell 136 235–248. (doi:10.1016/j.cell.2008.11.018)
79. Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J, Lu M, Li P, Yan Q, Zhu Y et al. 2012 Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nature Medicine 18 1407–1412. (doi:10.1038/nm.2885)
80. Tanaka T, Yoshida N, Kishimoto T & Akira S 1997 Defective adipocyte differentiation in mice lacking the C/EBPb and/or C/EBPd gene. EMBO Journal 16 7432–7443. (doi:10.1093/emboj/16.24.7432)
81. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R & Schutz G 1999 Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nature Genetics 23 99–103. (doi:10.1038/12703)
82. Tsaousidou E, Paeger L, Belgardt BF, Pal M, Wunderlich CM, Bronneke H, Collienne U, Hampel B, Wunderlich FT, Schmidt-Supprian M et al. 2014 Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance. Cell Reports 9 1495–1506. (doi:10.1016/j.celrep.2014.10.045)
83. Tschop J, Nogueiras R, Haas-Lockie S, Kasten KR, Castaneda TR, Huber N, Guanciale K, Perez-Tilve D, Habegger K, Ottaway N et al. 2010 CNS leptin action modulates immune response and survival in sepsis. Journal of Neuroscience 30 6036–6047. (doi:10.1523/JNEUROSCI.4875-09.2010)
84. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y et al. 2008 New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454 1000–1004. (doi:10.1038/nature07221)
85. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M & Hotamisligil GS 2006 Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. PNAS 103 10741–10746. (doi:10.1073/pnas.0603509103)
86. Vallerie SN, Furuhashi M, Fucho R & Hotamisligil GS 2008 A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS ONE 3 e3151. (doi:10.1371/journal.pone.0003151)
87. Vernia S, Cavanagh-Kyros J, Barrett T, Jung DY, Kim JK & Davis RJ 2013 Diet-induced obesity mediated by the JNK/DIO2 signal transduction pathway. Genes and Development 27 2345–2355. (doi:10.1101/gad.223800.113)
88. Vernia S, Cavanagh-Kyros J, Garcia-Haro L, Sabio G, Barrett T, Jung DY, Kim JK, Xu J, Shulha HP, Garber M et al. 2014 The PPARa-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway. Cell Metabolism 20 512–525. (doi:10.1016/j.cmet.2014.06.010)
89. Vogt MC & Bruning JC 2013 CNS insulin signaling in the control of energy homeostasis and glucose metabolism – from embryo to old age. Trends in Endocrinology and Metabolism 24 76–84. (doi:10.1016/j.tem.2012.11.004)
90. Waeber G, Delplanque J, Bonny C, Mooser V, Steinmann M, Widmann C, Maillard A, Miklossy J, Dina C, Hani EH et al. 2000 The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nature Genetics 24 291–295. (doi:10.1038/73523)
91. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL & Ferrante AW Jr 2003 Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112 1796–1808. (doi:10.1172/JCI200319246)
92. Whitmarsh AJ, Kuan CY, Kennedy NJ, Kelkar N, Haydar TF, Mordes JP, Appel M, Rossini AA, Jones SN, Flavell RA et al. 2001 Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes and Development 15 2421–2432. (doi:10.1101/gad.922801)
93. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA et al. 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 112 1821–1830. (doi:10.1172/JCI200319451)
94. Yang J, Croniger CM, Lekstrom-Himes J, Zhang P, Fenyus M, Tenen DG, Darlington GJ & Hanson RW 2005 Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein a. Journal of Biological Chemistry 280 38689–38699. (doi:10.1074/jbc.M503486200)
95. Yoon SO, Park DJ, Ryu JC, Ozer HG, Tep C, Shin YJ, Lim TH, Pastorino L, Kunwar AJ, Walton JC et al. 2012 JNK3 perpetuates metabolic stress induced by Ab peptides. Neuron 75 824–837. (doi:10.1016/j.neuron.2012.06.024)
96. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J & Lin A 2004 JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Molecular Cell 13 329–340. (doi:10.1016/S1097-2765(04)00028-0)
97. Zhang X, Xu A, Chung SK, Cresser JH, Sweeney G, Wong RL, Lin A & Lam KS 2011 Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle inmice. Diabetes 60 486–495. (doi:10.2337/db10-0650)